Results 211 to 220 of about 34,183 (229)

HIV-1 integrase inhibitor

Drug Discovery Today, 1996
openaire   +1 more source

Retroviral integrase inhibitors year 2000: update and perspectives

Antiviral Research, 2000
Yves Pommier, Nouri Neamati
exaly  

Review of Synthetic Routes and Final Forms of Integrase Inhibitors Dolutegravir, Cabotegravir, and Bictegravir

Organic Process Research and Development, 2019
David L Hughes
exaly  

Integrase inhibitors – neuropsychiatric tolerability

Zakażenia XXI wieku, 2018
openaire   +1 more source

Insight into integrase inhibitors

Inpharma Weekly, 2007
openaire   +1 more source

Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study

Lancet, The, 2013
Andrey Shuldyakov, Carlos Brites, Jaime F Andrade-Villanueva   +2 more
exaly  

A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors

Ca-A Cancer Journal for Clinicians
Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh   +2 more
exaly  

HIV-1 integrase inhibitors

The Biomedical & Life Sciences Collection, 2011
openaire   +1 more source

Integrase inhibitors go head-to-head

The Lancet HIV, 2017
openaire   +2 more sources

DNA Aptamers Derived from HIV-1 RNase H Inhibitors are Strong Anti-integrase Agents

Journal of Molecular Biology, 2002
Pierre-Yves Lozach, Ralf Altmeyer
exaly